With Forzinity, US FDA Accelerated Approval Still Can Precede Confirmatory Trial Enrollment

First and second priority
The FDA prioritized drug access over confirmatory trial initiation in its accelerated approval of Forzinity. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Review Profiles

More from United States